Skip to content

Complications of pulmonary thromboembolism after rapid performance of the team responsible for pulmonary embolism

Comparative study of the frequency of complications due to high-risk pulmonary thromboembolism after rapid performance of the team responsible for pulmonary embolism (TIMAR) compared to conventional performance

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210613051561N1
Enrollment
74
Registered
2021-06-21
Start date
2021-08-05
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary embolism. Pulmonary embolism

Interventions

Intervention 1: Intervention group: patients in this group, whose thromboembolism has been previously proven by CT scan and Geneva criteria, are visited and evaluated by a cardiology resident and trea

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age 18 to 75 years old Diagnosis of pulmonary thromboembolism based on the GENEVA criteria Patients with high-risk pulmonary embolism Satisfaction with entering this study

Exclusion criteria

Exclusion criteria: Dissatisfaction to continue participation in the study

Design outcomes

Primary

MeasureTime frame
Mortality rate. Timepoint: After interventions. Method of measurement: Check list.;Time of hospitalization. Timepoint: After interventions. Method of measurement: Check list.;Heart function. Timepoint: After interventions. Method of measurement: Eco cardiography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hadi Mansouri

Esfahan University of Medical Sciences

mansouri.hadi@gmail.com+98 31 3668 0042

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026